Global Immunohematology Market, By Product Type (Immunohematology Analyzer, Immunohematology Reagent), Technology (Microplates, Biochips, Gel Cards, Erythrocyte-Magnetized Technology, (EMT), Polymerase Chain Reaction), Application (Antibody Screening, Blood Typing), End User (Blood Banks, Hospitals, Diagnostic and Reference Laboratories, Academic and Research Institutes), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights of Immunohematology Market
Immunohematology market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 2422.07 million by 2028 and will grow at a CAGR of 4.19% in the above mentioned forecast period.
Immunohematology is usually known as blood banking. Immunohematology helps in the screening of Rh factor, blood antigens, plasma and white blood cell components in the donor blood. It is a division of hematology that studies antigen-antibody reactions and analogous phenomena as they associate to the pathogenesis and clinical manifestations of blood disorders.
The growing number of blood banks and trauma centers in developed countries is amongst the important factors intensifying the growth and demand of immunohematology market. In addition, the rising incidence rate of various hematological disorders as well as growing number of blood donation awareness programs in developing countries are also contributing to the growth in the global market over the forecast period of 2021 to 2028. Also the shifting preference to automated instrumentation and incorporation of different functions in a single platform are also enhancing the growth of the market. Furthermore, the high growth of innovative technologies for blood screening and new product launches is also one of the significant factors fueling the growth of the immunohematology market. Increasing incidence of blood cancer will make sure high industry growth over the forecast period.
The rapid technological advancements in immunohematology as well as the introduction of more advanced and innovative features of immunohematology devices will further accelerate the expansion of the immunohematology market and are also is offering significant growth opportunities for the market in the forecast period of 2021 to 2028.
However, the strict regulatory policies as well as lack of skilled professionals will curb the growth of the immunohematology market, whereas the high costs of techniques have the potential to challenge the growth of the immunohematology market.
This immunohematology market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on immunohematology market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Immunohematology Market Scope and Market Size
Immunohematology market is segmented on the basis of product type, technology, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on product type, the immunohematology market is segmented into immunohematology analyzer and immunohematology reagent. Immunohematology analyzer has further been segmented into automatic and semi-automatic/manual.
- On the basis of technology, the immunohematology market is segmented into microplates, biochips, gel cards, erythrocyte-magnetized technology, (EMT), and polymerase chain reaction.
- On the basis of application, the immunohematology market is segmented into antibody screening and blood typing.
- The end user segment of immunohematology market is segmented into blood banks, hospitals, diagnostic and reference laboratories and academic and research institutes.
Immunohematology Market Country Level Analysis
Immunohematology market is analyzed and market size insights and trends are provided by country, product type, technology, application and end user as referenced above.
The countries covered in the immunohematology market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the immunohematology market owing to the increasing number of trauma centers and blood bank facilities within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the strong presence of industry giants within this particular region.
The country section of the immunohematology market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Immunohematology market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for immunohematology market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the immunohematology market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Immunohematology Market Share Analysis
Immunohematology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to immunohematology market.
The major players covered in the immunohematology market report are Thermo Fisher Scientific Inc., Hologic, Inc., Merck KGaA, Beckman Coulter, Inc., Siemens Healthcare Private Limited, Grifols, Cardinal Health, CSL Limited, Ortho Clinical Diagnostics, Immucor, Inc., BD, HORIBA, Ltd., Abbott, MTC INVITRO DIAGNOSTICS AG, ANTISEL, Danaher, Sysmex Corporation, GSG Robotix, F. Hoffmann-La Roche Ltd., and Bio-Rad Laboratories, Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-